↓ Skip to main content

Non-bacterial cystitis caused by pembrolizumab therapy for adenocarcinoma of the lung: a case report

Overview of attention for article published in Frontiers in immunology, July 2024
Altmetric Badge

Mentioned by

reddit
1 Redditor
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Non-bacterial cystitis caused by pembrolizumab therapy for adenocarcinoma of the lung: a case report
Published in
Frontiers in immunology, July 2024
DOI 10.3389/fimmu.2024.1423123
Pubmed ID
Authors

Caixia Di, Teng Yu, Lei Ni

Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2024.
All research outputs
#23,843,428
of 26,538,769 outputs
Outputs from Frontiers in immunology
#28,855
of 33,363 outputs
Outputs of similar age
#236,309
of 298,239 outputs
Outputs of similar age from Frontiers in immunology
#444
of 840 outputs
Altmetric has tracked 26,538,769 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 33,363 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 298,239 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 840 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.